A multicenter EPIC (FiberNet Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet® Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published in the March 2010 issue of Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.

Members of the interventional cardiology community wish former President Bill Clinton a quick recovery following his recent hospitalization for angioplasty and stenting.

SCAI launched “WINHeart – Score a WIN for Women,” an initiative raising awareness surrounding gender-based disparities in the diagnosis, treatment and survival of women with cardiovascular disease (CVD). Women In Innovations (WIN), a group of interventional cardiologists within SCAI, released a new report and survey that illustrate why cardiovascular disease is under-recognized and under-treated in women despite the near split in prevalence of heart disease between men and women.

Pioneer of our profession and for many years was a dedicated, compassionate caregiver; Chief medical director at Boston Scientific. (1949-2009)

SCAI President Steven R. Bailey, M.D., FSCAI posted a response this morning to a Forbes.com article referencing the COURAGE and BARI-2D trials, cautioning that generalizing results from a subgroup of extensively evaluated patients to the broader population could have grave results.